Cyclosporine A and bromocriptine attenuate cell death mediated by intracellular calcium mobilization

Cyclosporine A and bromocriptine attenuate cell death mediated by intracellular calcium mobilization

To identify the novel inhibitors of endoplasmic reticulumstress-induced cell death, we performed a high throughput assaywith a chemical library containing a total of 3280 bioactive smallmolecules. Cyclosporine A and bromocriptine were identified aspotent inhibitors of thapsigargiin-induced cell deat...

Full description

Bibliographic Details
Main Author:	In Ki Kim1*, So Jung Park1, Jhang Ho Park1, Seung-Ho Lee2, Sung Eun Hong3 & John C. Reed3
Format:	Article
Language:	English
Published:	Korean Society for Biochemistry and Molecular Biology 2012-08-01
Series:	BMB Reports
Subjects:	Bromocriptine Calcium mobilization Cyclosporine A Endoplasmic reticulum stress
Online Access:	http://www.jbmb.or.kr/jbmb/pdf.php?data=MTMwMTIyMTdAcGRmX3JhaW50cmFjZV9sZWV5c0AlNUI0NS04JTVEMTIwODMwMTcyMF8lMjg0ODItNDg3JTI5Qk1CXzEyLTAyNC5wZGY=

Similar Items

Effect of cholestasis on Bromocriptine-induced yawning
by: Parviz M, et al.
Published: (1998-08-01)

A Case Report of Trigeminal Neuralgia after Taking Bromocriptine
by: Reza Bavarsad Shahripour
Published: (2011-07-01)

Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells
by: Mojgan Sheikhpour, et al.
Published: (2020-01-01)

A peripartum cardiomyopathy case treated with bromocriptine
by: Dilek Yeşilbursa, et al.
Published: (2021-03-01)

Repurposing of Bromocriptine for Cancer Therapy
by: Ean-Jeong Seo, et al.
Published: (2018-10-01)

Serum prolactin level in chronic urticaria: Is bromocriptine inducing remission in chronic urticaria?
by: Mohamed Soliman, et al.
Published: (2018-11-01)

Role of bromocriptine in multi-spectral manifestations of traumatic brain injury
by: Sunil Munakomi, et al.
Published: (2017-04-01)

Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease
by: Yasir Hasan Siddique, et al.
Published: (2016-01-01)

Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report
by: Saya Hakata, et al.
Published: (2019-06-01)

Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
by: Mitra Niafar, et al.
Published: (2016-03-01)

Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses
by: Caroline M. M. Loos, et al.
Published: (2022-05-01)

EFFECT OF OXYTOCIN AND BROMOCRIPTINE ON CORPORA LUTEA AND PSEUDOPREGNANCY IN MICE
by: N. A. S. AL- Khadi, et al.
Published: (1990-12-01)

Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
by: Yiqun Tang, et al.
Published: (2023-03-01)

Bromocriptine and insulin sensitivity in lean and obese subjects
by: L Bahler, et al.
Published: (2016-11-01)

Effectiveness of Bromocriptine, Fluoxetine and Nortriptyline in Ameliorating the Negative Symptoms of Schizophrenia
by: Saied Shoja-Shefti
Published: (2004-06-01)

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
by: A Ahmadi Ahangar, et al.
Published: (2002-07-01)

Induction of Ovulation with Clomiphene Citrate Versus Clomiphene with Bromocriptine in PCOS Patients with Normal Prolactin: A Comparative Study
by: Saswati Tripathy, et al.
Published: (2013-11-01)

The Effect of Concurrent Administration of Metoclopramide, Bromocriptine and Cumin Essential Oils on Rat Ovary
by: F Abbasi Hormozi, et al.
Published: (2016-07-01)

Bromocriptine in type 2 diabetes mellitus
by: C Shivaprasad, et al.
Published: (2011-01-01)

Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma
by: Motoyuki Igata, et al.
Published: (2021-04-01)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2
by: O A Gerasimenko, et al.
Published: (2011-12-01)

The Effect of Bromocriptine on the Disease Activity Index in Patients with Rheumatoid Arthritis
by: Mansour Salesi, et al.
Published: (2011-06-01)

Severe Hypoglycemia Due To the Administration of Bromocriptine in a Non-Diabetic Patient: A Case Study
by: Saeed Choobkar, et al.
Published: (2020-11-01)

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
by: Lijuan Bai, et al.
Published: (2023-08-01)

The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation
by: Karla Aidee Aguayo-Cerón, et al.
Published: (2020-10-01)

Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia
by: Harish Kumar V.S., et al.
Published: (2013-09-01)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
by: Via MA
Published: (2010-03-01)

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction
by: Vinita Sherwal, et al.
Published: (2010-01-01)

Effectivity of Bromocriptine Administration Towards Prolactin Positive Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Literature Review
by: Muhammad Yadi Permana, et al.
Published: (2023-10-01)

Evaluation of lipid profile and inflammatory parameters in female diabetes type 2 induced rabbits treated with glimepride,bromocriptine and fluoxtein
by: Duraid A. Abbas, et al.
Published: (2019-01-01)

Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet
by: Michael Ezrokhi, et al.
Published: (2021-06-01)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
by: Rebecca Simon, et al.
Published: (2018-10-01)

Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
by: Mulualem Tesfaye Birhan, et al.
Published: (2023-07-01)

Effect of using various doses of Bromocriptine in estrus induction and subsequent fertility in lactating anestrus Iraqi Ewes
by: Khammas D. J.
Published: (2017-01-01)

Formulation and Characterization of Bromocriptine Mesylate as Liquid Self-Nano Emulsifying Drug Delivery System
by: Zainab A. Hussein, et al.
Published: (2018-12-01)

Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine
by: Marianne F. Clausen, et al.
Published: (2021-12-01)

Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects
by: Anthony H. Cincotta
Published: (2023-08-01)

INTRACELLULAR Ca2+ HOMEOSTASIS
by: Shahdevi Nandar Kurniawan
Published: (2015-01-01)

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control
by: Yogendra Keche
Published: (2010-01-01)

Cyclosporine
by: Nahide Onsun
Published: (2022-04-01)